API Quick Links: http://en.hichipharm.com/

+86-152-0110-8103 yanglm@beilupharma.com

EN

EN
jp
fr
de
es
ru
pt
ar

- English
- 日本語
- français
- Deutsch
- Español
- русский
- português
- العربية

Hichi Pharmaceutical's Iodixanol API Approved for Market

2024/09/09

/uploads/image/2024/09/06/contrast-media-products-20240906-1.jpg

Iodixanol is the active pharmaceutical ingredient for iodixanol injection, a contrast agent used for intrathecal contrast, cardiovascular angiography, and intravenous urography. Its mechanism of action involves the absorption of X-rays by iodine in blood vessels or tissues, resulting in image display.

This time, Hichi Pharmaceutical's iodixanol active pharmaceutical ingredient obtained the "Chemical Active Pharmaceutical Ingredient Marketing Authorization Approval Notice." This not only enriches Hichi Pharmaceutical's active pharmaceutical ingredient variety and enhances its market competitiveness but also promotes the steady growth of Hichi Pharmaceutical's API sales business. Additionally, it will expand the depth and breadth of the company's integration of APIs and formulations in the field of contrast agents, creating favorable conditions for expanding the company's competitive advantage and market share in the contrast agent field.

Related Products

Ioversol Intermediate (order based) N, N'-Bis(2,3-dihydroxypropyl)-5-(glycoloylamino)-2,4,6-triiodoisophthalamide

Ioversol Intermediate (order based) N, N'-Bis(2,3-dihydroxypropyl)-5-(glycoloylamino)-2,4,6-triiodoisophthalamide

Ferric Ammonium Citrate Effervescent Granules

Ferric Ammonium Citrate Effervescent Granules

Gadobutrol Injection/API

Gadobutrol Injection/API

Related News

Beilu's Iopamidol Injection Won the Bid for China's Pharmaceutical Centralized Procurement
July 15, 2022On July 12, 2022, Beilu participated in the seventh batch of national centralized drug procurement organized by the National Organization for Centralized Drug Procurement and Use Joint Procurement Off...view
Anti Anxiety Drugs More Effective Than Blood Pressure Medication for Mood-induced Hypertension
July 5, 2022Young and middle-aged people face more problems in life, work, and emotion. So they are prone to anxiety, which can lead to high blood pressure. Therefore, it is important to control and relieve the a...view
Beilu Pharma's Contrast Media Production Line Passed EU GMP Certification.
November 14, 2024Recently, Beijing Beilu Pharmaceutical Co., Ltd. received the "Certificate Of GMP Compliance Of A Manufacturer" issued by the Dutch Medicines Evaluation Board in accordance with the relevant...view
Beilu Pharma Established a Wholly-owned R&D Subsidiary
September 7, 2022Taking the "Top 100 Chinese Pharmaceutical Enterprises" as the medium and long-term goal, Beilu Pharma has decided to choose not only the Contrast Agent field, Central Nervous System (Propri...view
Uses of Ferric Ammonium Citrate
December 27, 2021Ferric ammonium citrate is classified as a nutritional supplement, and it belongs to iron supplements. It is often used in the production and processing of wheat flour, cookies or baby milk powder. It...view
New Specifications of Repaglinide Tablets from Beilu Pharma Were Deemed to Have Passed the Generic Drugs Quality and Efficacy Consistency Evaluation
December 20, 2021Now, our company received the Notification of Approval of Supplementary Application for Repaglinide Tablets issued by the State Medical Products Administration (Notification No. : 2021 B04618). After ...view

Call us on:
+86-152-0110-8103
Email Us:
yanglm@beilupharma.com
No.3 Shuiyuan West Road, Miyun District, Beijing, China

Sitemap | Privacy Policy
Copyright © Beijing Beilu Pharmaceutical Co., Ltd. All Rights Reserved.

+86-152-0110-8103